Aims and Scope of Annals of the Rheumatic Diseases
The Annals of the Rheumatic Diseases is a peer-reviewed medical journal. It is co-owned by the BMJ Group and the European League Against Rheumatism and covers all aspects of rheumatology, including musculoskeletal conditions, arthritis, and connective tissue diseases. The journal publishes basic, clinical, and translational research and abstracts from conferences. The journal was established in 1939. It is available online by subscription and archived editions of the journal (older than one year) are available free of charge. Each issue, the editor-in-chief selects a paper to be published open access as an "Editors Choice". The editor-in-chief is Josef Smolen. Less
Key Metrics
CiteScore 

28.5
Eigenfactor 

0.05 - 0.1
H-Index 

272
Impact Factor 

>= 25
Scite Index 

0.88 5-Year SI

SJR 

Q1Immunology

SNIP 

5.22
Recommended pre-submission checks
Powered by 

Topics Covered on Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases Journal Specifications
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1935 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Annals of the Rheumatic Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Annals of the Rheumatic Diseases
Correspondence on 'Rheumatology and Long COVID: lessons from the study of fibromyalgia?' by Clauw and Calabrese.
- 27 Dec 2025
- Annals of the rheumatic diseases
Identification of novel fibroblast subsets in diffuse cutaneous systemic sclerosis.
- 27 Dec 2025
- Annals of the rheumatic diseases
Results of a 1-year randomised double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica.
- 20 Dec 2025
- Annals of the rheumatic diseases
Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multiomics analysis.
- 18 Dec 2025
- Annals of the rheumatic diseases
Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis.
- 17 Dec 2025
- Annals of the rheumatic diseases
Th9-arterial endothelial cell crosstalk promotes psoriatic atherosclerosis.
- 12 Dec 2025
- Annals of the rheumatic diseases
Correspondence on 'Rheumatology and Long COVID: lessons from the study of fibromyalgia?' by Clauw and Calabrese.
- 27 Dec 2025
- Annals of the rheumatic diseases
Identification of novel fibroblast subsets in diffuse cutaneous systemic sclerosis.
- 27 Dec 2025
- Annals of the rheumatic diseases
Results of a 1-year randomised double-blind placebo-controlled trial with methotrexate 25 mg/week in recently diagnosed polymyalgia rheumatica.
- 20 Dec 2025
- Annals of the rheumatic diseases
Shared and unique molecular signatures across different autoantibody groups in systemic sclerosis: a multiomics analysis.
- 18 Dec 2025
- Annals of the rheumatic diseases
Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis.
- 17 Dec 2025
- Annals of the rheumatic diseases
Th9-arterial endothelial cell crosstalk promotes psoriatic atherosclerosis.
- 12 Dec 2025
- Annals of the rheumatic diseases